GlassScriptPhysician profile
Anne Fabrizio
NPI 1629377023
$3,365.44
in general payments reported to CMS, 2019-2025
12 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,307 · 2022: $157 · 2023: $555 · 2024: $239 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.71 |
| Travel and Lodging | $293.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,544.21 | 2019-2023 | Da Vinci Surgical System |
| Thd America, INC. | $168.50 | 2024 | |
| Mylan Specialty L.P. | $157.46 | 2022 | |
| Boston Scientific Corporation | $122.90 | 2019 | |
| Davol INC. | $98.29 | 2023 | Arista Ah Flexitip |
| Ethicon US, LLC | $87.69 | 2023-2025 | Ethicon, Echelon; Endopath, Stratafix |
| Takeda Pharmaceuticals U.S.A., INC. | $67.37 | 2024-2025 | Gattex |
| Integra Lifesciences Corporation | $34.08 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Activ Surgical, INC. | $27.83 | 2023 | Activsight |
| Lilly USA, LLC | $21.17 | 2025 | Zepbound |
| Convatec INC. | $18.65 | 2024 | |
| W. L. Gore & Associates, INC. | $17.29 | 2025 | Gore Enform Preperitoneal Biomaterial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Fabrizio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.